21![Rationale for the EUCAST clinical breakpoints Rationale for the EUCAST clinical breakpoints](https://www.pdfsearch.io/img/e94e33f2d1f4101aa2a687b18905ae31.jpg) | Add to Reading ListSource URL: www.eucast.orgLanguage: English - Date: 2009-12-12 17:14:34
|
---|
22![New Drugs 4 Bad Bugs (ND4BB) Cross-project communication & collaboration COMBACTE (Topic 1) - Enabling New Drugs 4 Bad Bugs (ND4BB) Cross-project communication & collaboration COMBACTE (Topic 1) - Enabling](https://www.pdfsearch.io/img/9e3e857547fcdf999a1af783168abf6d.jpg) | Add to Reading ListSource URL: www.imi.europa.euLanguage: English - Date: 2014-03-05 10:28:43
|
---|
23![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/5a9d09db5de5da18f330005c76bc71f8.jpg) | Add to Reading ListSource URL: ahca.myflorida.comLanguage: English - Date: 2014-07-24 07:34:00
|
---|
24![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/6ed2d98ce1b5f086e564e4999844c01a.jpg) | Add to Reading ListSource URL: www.fdhc.state.fl.usLanguage: English - Date: 2014-07-24 07:34:00
|
---|
25![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/4b56b60dc768ca32429dee957fa6491f.jpg) | Add to Reading ListSource URL: www.fdhc.state.fl.usLanguage: English - Date: 2014-07-24 10:34:39
|
---|
26![Below is a list of the JCIH Risk Indicators for Permanent Early Onset and/or Late Progressive Hearing Loss in Childhood: Parent or caregiver concern* regarding hearing, speech, language or developmental delay. Below is a list of the JCIH Risk Indicators for Permanent Early Onset and/or Late Progressive Hearing Loss in Childhood: Parent or caregiver concern* regarding hearing, speech, language or developmental delay.](https://www.pdfsearch.io/img/b95a3a4e25acbd9b0dd5773557385567.jpg) | Add to Reading ListSource URL: dhhs.ne.govLanguage: English - Date: 2014-10-09 00:41:04
|
---|
27![Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anti-Infective Drugs Advisory Committee Meeting September 5, 2012 Location: The FDA White Oak Campus, Building 31, The Great Roo Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anti-Infective Drugs Advisory Committee Meeting September 5, 2012 Location: The FDA White Oak Campus, Building 31, The Great Roo](https://www.pdfsearch.io/img/ecbf698cce6f8fd044789ea91052ec7f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
28![NDA[removed]S-015 Page 3 Zylet™ loteprednol etabonate and tobramycin ophthalmic suspension, 0.5%/0.3% NDA[removed]S-015 Page 3 Zylet™ loteprednol etabonate and tobramycin ophthalmic suspension, 0.5%/0.3%](https://www.pdfsearch.io/img/eb22b7cecc690e950aa7e3923978da40.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-06-07 09:50:05
|
---|
29![rccm2010091478ci[removed] rccm2010091478ci[removed]](https://www.pdfsearch.io/img/04c76450f81efef2fd12411ea80f4bd3.jpg) | Add to Reading ListSource URL: cfcenter.stanford.eduLanguage: English - Date: 2011-06-06 12:40:44
|
---|
30![Beneficiary’s Medicaid ID# Beneficiary’s Medicaid ID#](https://www.pdfsearch.io/img/6b9ee2db9fea37509c06b8ae80ac1dae.jpg) | Add to Reading ListSource URL: www.ahca.myflorida.comLanguage: English - Date: 2014-07-24 10:34:39
|
---|